Several ethylene-response factor (ERF) transcription factors are believed to play a crucial role in the activation of plant defence responses, but little is known about the relationships between the diversity of this family and the functions of groups or individual ERFs in this process. In this study, 200 ERF genes from the unigene cotton database were identified. Conserved amino acid residues and phylogeny reconstruction using the AP2 conserved domain suggest that the classification into 10 major groups used for Arabidopsis and rice is applicable to the cotton ERF family. Based on in silico studies, we predict that group IX ERF genes in cotton are involved in jasmonate (JA), ethylene (ET) and pathogen responses. To test this hypothesis, we analysed the transcript profiles of the group IXa subfamily in the regulation of specific resistance to Xanthomonas campestris pathovar malvacearum. The expression of four members of group IXa was induced on challenge with X. campestris pv. malvacearum. Furthermore, the expression of several ERF genes of group IXa was induced synergistically by JA in combination with ET, suggesting that the encoded ERF proteins may play key roles in the integration of both signals to activate JA- and ET-dependent responses.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640365PMC
http://dx.doi.org/10.1111/j.1364-3703.2009.00549.xDOI Listing

Publication Analysis

Top Keywords

group ixa
16
erf genes
12
cotton erf
8
erf transcription
8
transcription factors
8
jasmonate ethylene
8
malvacearum expression
8
ixa induced
8
erf
7
group
5

Similar Publications

Article Synopsis
  • - In vitro studies show that kidney transplants from gene-edited pigs may face more challenges in nonhuman primates (NHPs) than in humans, but pig-to-human transplants have distinct advantages like better communication with the surgical team and improved monitoring methods.
  • - Advantages for recipients of xenotransplants include better clinical-grade microbiological management, access to advanced monitoring and imaging techniques, and available therapeutic interventions not easily accessible in NHP models.
  • - To expedite safe human clinical trials, it's proposed to start small pilot cases for high-risk patients, particularly those over 60, with specific blood types, or diabetic nephropathy, as many patients on the kidney waitlist die each year due to lack of alternatives.
View Article and Find Full Text PDF

Optimal therapy for the growing number of patients with lenalidomide (LEN)-refractory multiple myeloma in their first relapse remains poorly defined. We therefore undertook a randomized phase 2 study to evaluate the efficacy and safety of combining the oral proteasome inhibitor ixazomib (IXA) with pomalidomide (POM) and dexamethasone (DEX) in this patient population. The overall response rate (ORR) for POM-DEX was 43.

View Article and Find Full Text PDF

Intermediate molecular weight-fucosylated chondroitin sulfate from sea cucumber Cucumaria frondosa is a promising anticoagulant targeting intrinsic factor IXa.

Int J Biol Macromol

June 2024

CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Center for Ocean Mega-Science, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China; Laboratory for Marine Drugs and Bioproducts, Qingdao National Laboratory for Marine Science and Technology, No. 1 Wenhai Road, Qingdao 266237, China.

Thromboembolic diseases pose a serious risk to human health worldwide. Fucosylated chondroitin sulfate (FCS) is reported to have good anticoagulant activity with a low bleeding risk. Molecular weight plays a significant role in the anticoagulant activity of FCS, and FCS smaller than octasaccharide in size has no anticoagulant activity.

View Article and Find Full Text PDF

Genotypic and phenotypic features of 39 Chinese patients with glycogen storage diseases type I, VI, and IX.

Clin Genet

September 2024

Gastroenterology Department, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.

Article Synopsis
  • - Glycogen storage diseases (GSDs) are inherited disorders affecting glycogen metabolism, primarily in the liver, muscles, and heart, caused by genetic mutations that lead to deficiencies in specific proteins.
  • - A study of 39 patients in China utilized next-generation sequencing to diagnose various GSD subtypes, revealing 20 cases of GSD-Ia, 4 of GSD-VI, and 15 of GSD IX, with several novel mutations identified in key genes.
  • - The research highlights the rarity of hearing impairment in GSD Ia patients and suggests the need for careful monitoring of severity in GSD VI and IX cases, contributing to a better understanding of genotype-phenotype relationships in GSDs.
View Article and Find Full Text PDF

An effective anticoagulation therapy is required for patients with atrial fibrillation because it presents a significant risk of stroke. The current study evaluates the relative safety as well as efficacy of rivaroxaban in patients who are diagnosed with atrial fibrillation. A thorough literature review of relevant databases was conducted, focusing on academic and clinical studies that were published from 2017 onward.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!